Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: Myocardial and tissue distribution

Drug Metabolism and Disposition

Volumn 33, Issue 8, 2005, Pages 1101-1107

  Laham, Roger J ^a   Post, Mark ^a   Rezaee, Mehrdad ^a   Donnell Fink, Laurel ^a   Wykrzykowska, Joanna J ^a   Lee, Seung U ^a   Baim, Donald S ^b   Sellke, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; IODINE 125;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; FEMALE; HEART CONTRACTION; HEART MUSCLE; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; AUTORADIOGRAPHY; CORONARY CIRCULATION; DRUG DELIVERY SYSTEMS; ENDOCARDIUM; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEART CATHETERIZATION; INJECTIONS; IODINE RADIOISOTOPES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PERICARDIUM; SWINE; THORACOTOMY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 22944447755     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.002774     Document Type: Article

References (30)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
2. Bagheri-Yarmand R, Kourbali Y, Mabilat C, Morere JF, Martin A, Lu H, Soria C, Jozefonvicz J, and Crepin M (1998) The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). Br J Cancer 78:111-118.
3. Ben-Haim SA, Osadchy D, Schuster I, Gepstein L, Hayam G, and Josephson ME (1996) Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 2:1393-1395.
4. Edelman ER, Nugent MA, and Karnovsky MJ (1993) Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc Natl Acad Sci USA 90:1513-1517.
5. Faham S, Hileman RE, Fromm JR, Linhardt RJ, and Rees DC (1996) Heparin structure and interactions with basic fibroblast growth factor. Science (Wash DC) 271:1116-1120.
6. Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36:127-137.
7. Gabra N, Khayat A, Calabresi P, and Khiat A (1994) Detection of elevated basic fibroblast growth factor during early hours of in vitro angiogenesis using a fast ELISA immunoassay [published erratum appears in Biochem Biophys Res Commun 1995 May 16;210(2):638]. Biochem Biophys Res Commun 205:1423-1430.
8. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, and Simons M (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Investig 94:623-630.
9. Hariawala MD, Horowitz JJ, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, and Symes JF (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63:77-82.
10. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, et al. (2003) The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107:1359-1365.
11. Kornowski R, Hong MK, Haudenschild CC, and Leon MB (1998) Feasibility and safety of percutaneous laser revascularization using the Biosense system in porcine hearts. Coron Artery Dis 9:535-540.
12. Kornowski R, Leon MB, Fuchs S, Vodovotz Y, Flynn MA, Gordon DA, Pierre A, Kovesdi I, Keiser JA, and Epstein SE (2000) Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 35:1031-1039.
13. Laham R, Hung D, and Simons M (1999a) Subxyphoid access of the normal pericardium: a novel drug delivery technique. Catheter Cardiovasc Interv 47:109-111.
14. Laham R, Rezaee M, Post M, Novicki D, Sellke F, Pearlman J, Simons M, and Hung D (2000a) Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 292:795-802.
15. Laham R, Rezaee M, Post M, Xu X, and Sellke F (2003) Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration. Catheter Cardiovasc Interv 58:375-381.
16. Laham RJ, Chronos NA, Pike M, Leimbach ME, Udelson JE, Pearlman JD, Pettigrew RI, Whitehouse MJ, Yoshizawa C, and Simons M (2000b) Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J Am Coll Cardiol 36:2132-2139.
17. Laham RJ, Rezaee M, Post M, Sellke FW, Braeckman RA, Hung D, and Simons M (1999b) Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. Drug Metab Dispos 27:821-826.
18. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, and Simons M (1999c) Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100:1865-1871.
19. Laham RJ, Simons M, Pearlman JD, Ho KK, and Baim DS (2002) Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization. J Am Coll Cardiol 39:1-8.
20. Lopez JJ, Laham RJ, Stamler A, Pearlman JD, Bunting S, Kaplan A, Carrozza JP, Sellke FW, and Simons M (1998) VEGF administration in chronic myocardial ischemia in pigs. Cardiovasc Res 40:272-281.
21. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, and Isner JM (1998) Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804.
22. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, et al. (1999) Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474.
23. Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, and Sellke FW (2002) Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 124:28-34.
24. Schaper W (1996) Collateral vessel growth in the human heart. Role of fibroblast growth factor-2. Circulation 94:600-601.
25. Schumacher B, Pecher P, von Specht B, and Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors. Circulation 97:645-650.
26. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, et al. (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788-793.
27. Simons M and Laham RJ (1999) Therapeutic angiogenesis in myocardial ischemia, in Angiogenesis and Cardiovascular Disease (Ware J and Simons M eds), pp 289-320, Oxford University Press, New York.
28. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, and Isner JM (1999) Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68:830-836; discussion 836-837.
29. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, and Epstein SE (1994) Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266:H1588-H1595.
30. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, and Kurashima C (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science (Wash DC) 257:1401-1403.